Literature DB >> 10971525

Islet xenograft destruction in the hu-PBL-severe combined immunodeficient (SCID) mouse necessitates anti-CD3 preactivation of human immune cells.

C Gysemans1, M Waer, J Laureys, J Depovere, D Pipeleers, R Bouillon, C Mathieu.   

Abstract

Introduction of the hu-PBL-SCID mouse model has yielded a potentially useful tool for research in transplantation. The aim of this study was to define the conditions necessary for a reconstituted human immune system to destroy in a consistent manner rat islet xenografts in the alloxan-diabetic hu-PBL-SCID mouse. We examined different time points of hu-PBL reconstitution, different transplantation sites of the islets and several hu-PBL reconstitution protocols. Major differences in graft destruction were observed between the different hu-PBL reconstitution protocols, irrespective of timing of hu-PBL reconstitution or site of transplantation. Although preactivation of hu-PBL did not improve the level of hu-PBL chimerism, histological and immunohistochemical analysis of the grafts revealed a severe human lymphocytic infiltration and beta cell destruction only in the grafts of mice receiving preactivated hu-PBL. This beta cell injury resulted in impaired glucose tolerance, with in some animals recurrence of hyperglycaemia, and decreased insulin and C-peptide levels after glucose stimulation. Therefore, we conclude that activation of hu-PBL prior to transfer is essential in achieving xenograft infiltration and destruction in hu-PBL-SCID mice. The need for immune manipulation suggests that interactions between hu-PBL and xenografts in this model may be hampered by incompatibilities in cross-species adhesion and/or activation signals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10971525      PMCID: PMC1905726          DOI: 10.1046/j.1365-2249.2000.01300.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

1.  Facilitated engraftment of human hematopoietic cells in severe combined immunodeficient mice following a single injection of Cl2MDP liposomes.

Authors:  W Terpstra; P J Leenen; C van den Bos; A Prins; W A Loenen; M M Verstegen; S van Wyngaardt; N van Rooijen; A W Wognum; G Wagemaker; J J Wielenga; B Löwenberg
Journal:  Leukemia       Date:  1997-07       Impact factor: 11.528

2.  No correlation between in vitro and in vivo function of human islets.

Authors:  I C Gerling; M Kotb; D Fraga; O Sabek; A O Gaber
Journal:  Transplant Proc       Date:  1998-03       Impact factor: 1.066

3.  Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine.

Authors:  K Casteels; M Waer; J Laureys; D Valckx; J Depovere; R Bouillon; C Mathieu
Journal:  Transplantation       Date:  1998-05-15       Impact factor: 4.939

Review 4.  Pancreatic islet transplantation.

Authors:  K Salmela
Journal:  Ann Chir Gynaecol       Date:  1997

5.  Pig but not human interferon-gamma initiates human cell-mediated rejection of pig tissue in vivo.

Authors:  P Sultan; A G Murray; J M McNiff; M I Lorber; P W Askenase; A L Bothwell; J S Pober
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

6.  Prevention of type I diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1,25-dihydroxyvitamin D3 in combination with a short induction course of cyclosporin A.

Authors:  K M Casteels; C Mathieu; M Waer; D Valckx; L Overbergh; J M Laureys; R Bouillon
Journal:  Endocrinology       Date:  1998-01       Impact factor: 4.736

7.  A severe combined immunodeficiency mutation in the mouse.

Authors:  G C Bosma; R P Custer; M J Bosma
Journal:  Nature       Date:  1983-02-10       Impact factor: 49.962

8.  Peritoneal macrophages play an important role in eliminating human cells from severe combined immunodeficient mice transplanted with human peripheral blood lymphocytes.

Authors:  S Shibata; T Asano; A Noguchi; M Naito; A Ogura; K Doi
Journal:  Immunology       Date:  1998-04       Impact factor: 7.397

Review 9.  The Trimera mouse: generating human monoclonal antibodies and an animal model for human diseases.

Authors:  Y Reisner; S Dagan
Journal:  Trends Biotechnol       Date:  1998-06       Impact factor: 19.536

10.  Evidence of functional lymphocytes in some (leaky) scid mice.

Authors:  G C Bosma; M Fried; R P Custer; A Carroll; D M Gibson; M J Bosma
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more
  4 in total

1.  Four-color flow cytometric analysis of peripheral blood donor cell chimerism.

Authors:  Diana Metes; Alison Logar; William A Rudert; Adriana Zeevi; Jennifer Woodward; Anthony J Demetris; Kareem Abu-Elmagd; Bijan Eghtesad; Ron Shapiro; John J Fung; Massimo Trucco; Thomas E Starzl; Noriko Murase
Journal:  Hum Immunol       Date:  2003-08       Impact factor: 2.850

2.  Treatment of autoimmune diabetes recurrence in non-obese diabetic mice by mouse interferon-beta in combination with an analogue of 1alpha,25-dihydroxyvitamin-D3.

Authors:  C Gysemans; E Van Etten; L Overbergh; A Verstuyf; M Waer; R Bouillon; C Mathieu
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

3.  Evaluation of the tolerogenic effects of donor bone marrow cells using a severe combined immunodeficient mouse-human islet transplant model.

Authors:  James M Mathew; Bonnie Blomberg; Camillo Ricordi; Violet Esquenazi; Joshua Miller
Journal:  Hum Immunol       Date:  2008-08-12       Impact factor: 2.850

4.  Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice.

Authors:  A Giulietti; C Gysemans; K Stoffels; E van Etten; B Decallonne; L Overbergh; R Bouillon; C Mathieu
Journal:  Diabetologia       Date:  2004-01-31       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.